1. Pauletti G, Dandekar S, Rong H, Ramos L, Peng H, Seshadri R, Slamon D: Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry. J Clin Oncol 18: 3651–3664, 2000
2. Press MF, Sauter G, Bernstein L, Zhou J, Li B, Mirlacher M, Villalobos I, Guzman R, Riva A, Nabholtz J-M, Slamon DJ: Comparison of HER-2/neu status determined by fluorescence in situ hybridization (FISH) in the BCIRG central laboratories with HER-2/neu status determined by immunohistochemistry or FISH in outside laboratories [abstract]. Breast Cancer Res Treat 76(Suppl 1): S69, 2002 (Abstract 238)
3. Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ: Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci USA 89: 10578–10582, 1992
4. Chazin VR, Kaleko M, Miller AD, Slamon DJ: Transformation mediated by the human HER-2 gene independent of the epidermal growth factor receptor. Oncogene 7: 1859–1866, 1992
5. Muller WJ, Ho J, Siegel PM: Oncogenic activation of Neu/ErbB-2 in a transgenic mouse model for breast cancer. Biochem Soc Symp 63: 149–157, 1998